Optic Glioma

Overview

An optic glioma is a tumor that grows from the supportive (glial) cells along the optic nerve and the visual pathways that carry signals from the eyes to the brain. Most are low-grade, meaning they grow slowly and rarely spread, although their location near the eyes and brain can still cause problems.

Optic gliomas are most common in children and are strongly associated with the genetic condition neurofibromatosis type 1 (NF1). Many slow-growing optic gliomas, especially in children with NF1, cause few or no symptoms and may simply be watched over time. Others affect vision or, when they involve nearby brain structures, hormones and other functions, and may need active treatment.

Symptoms

Symptoms depend on the tumor's size and exact location along the optic pathway. Some children have no symptoms and the tumor is found incidentally. When present, signs may include:

• Gradual loss or blurring of vision in one or both eyes
• Reduced color vision or loss of side (peripheral) vision
• A bulging or outward-turning eye
• Involuntary, rapid eye movements (nystagmus), more often in infants
• In tumors near the brain's hormone center: early or delayed puberty, slowed growth, or excessive thirst and urination
• Headache or, less often, signs of raised pressure in the brain

Causes

Optic gliomas arise from abnormal growth of glial cells in the optic nerve or pathways. The exact trigger is not always known.

• Neurofibromatosis type 1 (NF1): A genetic condition that greatly increases the risk of optic glioma; many childhood optic gliomas occur in children with NF1.
• Sporadic cases: Optic gliomas can also occur in children and, less often, adults who do not have NF1.

These tumors are not caused by anything a parent did during pregnancy and are not contagious.

Risk Factors

• Neurofibromatosis type 1 (the strongest risk factor)
• Young age, as most optic gliomas appear in childhood
• A family history of NF1

Diagnosis

Diagnosis combines eye and brain assessment.

• Eye examination: Testing vision, color vision, peripheral vision, and the appearance of the optic nerve.
• MRI scan: The main test, showing the tumor along the optic nerve or pathways and how far it extends.
• Evaluation for NF1: Checking for other features of neurofibromatosis.
• Biopsy: Rarely needed, as MRI features are often characteristic, but used in uncertain cases.

Children with NF1 are often screened with regular eye exams so any optic glioma is found early.

Treatment

Treatment is individualized and depends on the tumor's growth, its effect on vision, and the child's overall situation.

• Observation: Many slow-growing optic gliomas, especially in NF1, are simply monitored with regular eye exams and MRI scans if they are stable and not affecting vision.
• Chemotherapy: The usual first treatment when a tumor is growing or threatening vision, often preferred over radiation in young children.
• Targeted therapy: Newer medicines that block specific tumor growth pathways are increasingly used in certain cases.
• Surgery: Considered in selected situations, such as a large tumor causing severe symptoms or a badly bulging, blind eye.
• Radiation therapy: Used in some older patients, but generally avoided in young children to protect the developing brain.

Care is usually provided by a team including eye specialists, neuro-oncologists, and others.

Prevention

Optic gliomas cannot be prevented, because they arise from changes in cell growth. The focus is on early detection and protecting vision:

• Regular eye examinations for children known to have neurofibromatosis type 1
• Prompt evaluation of any new vision change or eye bulging
• Genetic counseling for families affected by NF1

When to See a Doctor

See a doctor if a child develops blurred or reduced vision, a bulging or wandering eye, or unusual eye movements. Seek prompt medical care for:

• New or worsening vision loss
• A persistent headache with vomiting, especially in the morning
• Signs of raised pressure in the brain, such as drowsiness or balance problems
• Unexplained early or delayed puberty or slowed growth

Related Topics

Frequently Asked Questions

References

1. National Cancer Institute (NCI). Childhood Astrocytomas and Other Gliomas Treatment.
2. Children's Tumor Foundation. Neurofibromatosis and Optic Pathway Glioma.
3. MedlinePlus, U.S. National Library of Medicine. Optic nerve glioma.
4. American Academy of Ophthalmology. Optic Nerve Glioma.